An international clinical trial published in the Lancet with patients recruited from Manchester and Sheffield has shown that dupilumab is

highly effective in controlling severe eczema in children has young as 6 months old and is not available in the UK in children down to this age.

To read full article click here.

WordPress Video Lightbox Plugin